Toxic effects of epidural analgesia with ropivacaine 0.2% in a diabetic patient.
A 51-year-old ASA physical status II, non-insulin-dependent diabetic male patient manifested lower limb nerve injury after receiving postoperative epidural analgesia with ropivacaine 0.2%. The case is presented, including a discussion of the relation between local anesthetic toxicity and diabetic neuropathy.
Al-Nasser
Bassam
B
Clinique du Parc Saint Lazare, Beauvais, France. balnasser@wanadoo.fr
D020269:Alcoholic Neuropathy / Q000150:complications; D000577:Amides / Q000009:adverse effects*; D015360:Analgesia, Epidural / Q000009:adverse effects*; D000779:Anesthetics, Local / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003929:Diabetic Neuropathies / Q000150:complications; D004576:Electromyography; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000139:chemically induced; D010292:Paresthesia / Q000139:chemically induced; D011115:Polyneuropathies / Q000139:chemically induced*; D011183:Postoperative Complications / Q000139:chemically induced; D011468:Prostatectomy / Q000379:methods; D012021:Reflex, Abnormal; D000077212:Ropivacaine
D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine